Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice

AIMS/HYPOTHESIS: Abnormal cannabidiol (Abn-CBD) and AS-1269574 are potent selective agonists for GPR55 and GPR119, respectively. The present study evaluated the actions and ability of these small-molecule agonists to counteract experimental diabetes in mice. METHODS: Diabetes was induced in NIH Swis...

Descripción completa

Detalles Bibliográficos
Autores principales: McKillop, Aine M., Moran, Brian M., Abdel-Wahab, Yasser H. A., Gormley, Noella M., Flatt, Peter R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518089/
https://www.ncbi.nlm.nih.gov/pubmed/27677765
http://dx.doi.org/10.1007/s00125-016-4108-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518089/
https://www.ncbi.nlm.nih.gov/pubmed/27677765
http://dx.doi.org/10.1007/s00125-016-4108-z

Ejemplares similares